Molecular Analysis of DNA Polymerase Eta Gene in Japanese Patients Diagnosed as Xeroderma Pigmentosum Variant Type  by Tanioka, Miki et al.
Molecular Analysis of DNA Polymerase Eta Gene in
Japanese Patients Diagnosed as Xeroderma
Pigmentosum Variant Type
Miki Tanioka1,2,6, Taro Masaki1,6, Ryusuke Ono1, Tohru Nagano1, Eriko Otoshi-Honda2,
Yasuhiro Matsumura2, Masahiro Takigawa3, Hiroki Inui4, Yoshiki Miyachi2, Shinichi Moriwaki3,5 and
Chikako Nishigori1
POLH mutations were identified in 16 Japanese patients, who were diagnosed, both clinically and at a cellular
level, as being of the xeroderma pigmentosum variant type (XPV). While all the patients developed skin cancer
with an average onset of the cancer at 45 years, in non-XP Japanese the onset was at over 70 years. All the cell
strains from the patients were normal or slightly hypersensitive to UV and most of these showed enhanced UV
sensitivity when the post-UV colony formation was performed in the presence of caffeine. Immunoprecipita-
tion analysis with two kinds of anti-POLH protein antibodies revealed that cells from 13 patients did not show
the 83 kDa POLH band and that cells from one patient had a faint 83 kDa band. All of these 14 cell strains,
without a POLH band or with a weak POLH band, had mutations in the POLH gene. The IP analysis of the POLH
protein revealed a very useful method for screening the patients suspected of XPV. Seven mutations in the
POLH gene including three novel mutations were identified. Among the mutations detected, 11 alleles out of 28
(39%) were G490T mutations.
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INTRODUCTION
Xeroderma pigmentosum (XP) is an autosomal recessively
inherited disease, characterized by extremely high sensitivity
to sunlight, and it occurs at a higher frequency (1:40,000) in
Japan than (1:250,000) in the United States (Robbins et al.,
1974; Takebe et al., 1987). XP is classified into seven genetic
complementation groups of nucleotide excision repair (NER)-
deficient type, A–G (XPA–G) (Wood, 1996), and a NER
proficient xeroderma pigmentosum variant type (XPV).
Approximately one-fourth of the XP patients in Japan may
belong to the XPV type (OMIN 278750) (Takebe et al., 1987).
The products of the genes responsible for XPA–G are involved
in one of the steps in the NER process (Kraemer et al., 1987).
On the other hand, cells from patients with XPV show normal
levels of NER but an exaggerated delay in the recovery of the
replicative DNA synthesis after UV irradiation (Cleaver and
Kraemer, 1995). The overall clinical course of patients with
XPV is more favorable than for those with severe types of
NER-deficient XPs such as A, B, C, D, and G, in that they
develop skin tumors later and in that complications with
neurological abnormalities are extremely rare in XPV. The
XPV cDNA was cloned and its product was identified as DNA
polymerase eta (POLH, Genbank accession number
NM006502), an enzyme that enables the cells to synthesize
the correct daughter strands, despite the presence of thymine
dimmers, on to the UV-damaged template DNA (Johnson
et al., 1999; Masutani et al., 1999). After the cloning of the
cDNA, genetic analysis revealed many mutation sites in the
POLH gene in patients with XPV (Johnson et al., 1999;
Masutani et al., 1999; Broughton et al., 2002). However,
most of the studies have been performed for Caucasian and
African-American individuals. Here, we report the molecular
analysis of mutations in the POLH gene in new Japanese
patients with possible XPV.
RESULTS
UV sensitivity and UV-induced unscheduled DNA synthesis
The levels of UV-induced unscheduled DNA synthesis (UDS)
in the XPV cells were normal or slightly lower than normal
(Table 1). In the post-UV colony-forming assay, the D37 of
XPV cells without caffeine showed normal or slight sensitivity
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to UV; however, 14 of the 15 strains revealed a much higher
sensitivity to UV in the presence of caffeine (Table 1).
Mutant screening by immunoprecipitation of POLH protein
We used immunoprecipitation (IP) analysis with two kinds of
anti-POLH protein antibodies to identify the POLH protein in
the cells. Normal human cells and XPV cells were solubilized
and used for IP. On SDS-PAGE analysis (Figure 1), a protein
with a molecular mass of 83 kDa was precipitated from
normal cells (lanes 1, 5, 10 in Figure 1), whereas no 83 kDa
band for POLH protein was detected for the 13 patients
(Figure 1; data for all patients are not shown). On the other
hand, cells from XPV3KO had a relatively weak 83 kDa band
(lane 6 in Figure 1). Densitometric measurement of the band
for XPV3KO cells showed that it was about one-tenth of that
in normal cells. The densitometric measurement of the
83 kDa band in XPV3HM and XPV7KO cells was within
normal levels, although their clinical features and cellular
characteristics, such as increased UV sensitivity in the
presence of caffeine, were compatible with XPV.
Mutation analysis
Subsequent sequence analysis revealed that cells without an
83 kDa band and with a weak 83 kDa band had generated the
alterations in the POLH gene. In contrast, XPV3HM and
XPV7KO, with normal signal intensity levels of the 83 kDa
band, did not carry POLH mutations (Table 2). Cells without
the 83 kDa band comprised the following: homozygous
nonsense mutation (XPV2HM, XPV6HM, XPV11HM,
XPV4KO, and XPV6KO), homozygous splicing mutation
(XPV1HM, XPV7HM, XPV10HM, XPV2KO, and XPV5KO),
homozygous frameshift mutation (XPV12HM), and com-
pound heterozygous mutation (XPV8HM and XPV1KO).
Table 1. Clinical and cellular characters of the patients in this study
UV survival1 UV survival
Case no. Cell strain Age (years) Sex UDS (%) D37 in caffeine () D37 in caffeine (+) Age onset of skin cancers2 (years)
1 XPV1HM 82 M 109 5.1 2 3 SCCs (57), BCC (71), 2 AKs (76)
2 XPV2HM 68 M 87 5 2 BCC (57), multiple MM
3 XPV3HM 69 F 70 3.1 1.2 SCC (69), multiple AK
4 XPV6HM 53 M 75 6.2 1.3 2 BCCs (37), 1 MM (52)
5 XPV7HM 54 M 115 5.8 2.2 SCC (47)
6 XPV8HM 39 F 96 5.5 2.1 Multiple BCC (25)
7 XPV10HM 67 M 105 5.9 2.2 3 SCCs (47)
8 XPV11HM 69 M 70 6.8 4.2 BCC (59)
9 XPV12HM 45 M 66 4.2 3.1 SCC (43)
10 XPV1KO 34 F 108 4.6 3 BCC (24), multiple skin cancers
11 XPV2KO 69 M 91 4.5 2 BCC (22), KA (34)
12 XPV3KO 50 M 88 5.5 2.3 MM (56)
13 XPV4KO 55 M 55 5.6 2.1 BCC multiple SCC
14 XPV5KO 57 F 75 1.5 ND SCC (45), multiple AKs
15 XPV6KO 55 F 92.1 2.3 1.3 SCC (54)
16 XPV7KO 48 F 101 6 3 AK (47), LM (47)
AK, actinic keratosis; BCC, basal cell carcinma; F, female; LM, lentigo maligna; M, male; MM, malignant melanoma; ND, not determined; SCC, squamous
cell carcinoma; UDS, unscheduled DNA synthesis.
1D37 of normal cells without caffein are between 4.5 and 6.
2The number berore the word (SCC, BCC, etc) means the number of cancers patients ever had. The number in parenthesis indicates the age onset of the
tumor.
134 kDa
N
or
m
a
l
N
or
m
a
l
N
or
m
a
l
XP
V8
HM
XP
V1
1H
M
XP
V5
KO
XP
V3
KO
XP
V4
KO
XP
V6
KO
XP
V2
KO
83 kDa
41 kDa
Lane 1 2 3 4 5 6 7 8 9 10
Figure 1. POLH protein was not detected in patients with XPV. IP analyses of
a normal individual and patients with XPV are shown. No 83 kDa bands were
detected in patients with XPV (lanes 2, 3, 4, 7, 8, and 9). A relatively weak
band was detected in XPV3KO (lane 6). Background (nonspecific bands)
indicates that the amount of the loaded extract was equal in the lanes.
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XPV3KO cells with a weak 83 kDa band carried homozygous
missense mutations. Two missense mutations (K589T in
XPV8HM and A117P in XPV3KO) were not found in the
genomic DNA from 50 non-affected unrelated Japanese
individuals or from the SNP database network in Japan (http://
snpnet.jst.go.jp/top_e.html).
Aberrant splicing of POLH pre-mRNA in XPV1KO and
XPV2KO cells
As the mutation at the last nucleotide of the exon 4 (G490T)
alters the consensus sequence at the 30 splice donor site of
exon 4, from AGgt (the capital letters and small letters
indicate nucleotides in exon and intron, respectively) to ATgt,
we examined the aberrant pre-mRNA splicing in XPV2KO
cells (homozygote of G490T), and XPV1KO (compound
heterozygote of G490T and G916T, nonsense mutation)
by determining the sequence of the reverse transcriptase
(RT)-PCR products.
The following are shown in Figure 2a: DNA fragments
amplified by the RT-PCR from the mRNA of a normal
individual, XPV1KO and XPV2KO primed with RT-E1F and
RT-E10R (see Materials and Methods), and an agarose gel
electrophoresis (Figure 2a). Bands I through VI were excised
from the gel and sequenced. Band VI in the normal individual
had the normal POLH cDNA sequence, and the size of
the product was 1,102 bp. The size of band II in XPV1KO
was 1,102 bp, corresponding to the G916T that results in the
Glu-306-stop. Bands I and III from XPV1KO, and IV and V
from XPV2KO, were produced by transcription from the
aberrant splicing caused by G490T. The sizes of bands I and
IV that contained the former part of intron 4 were 1,265 bp
and were designated as def A. The sizes of bands III and V
that lacked the latter parts of exon 4 were 1,012 bp and were
designated as def B. No mRNA with normal sequence was
detected in either the XPV1KO or XPV2KO cells.
The RT-PCR products in the XPV2KO cells indicated that
two types of mRNA (def A and def B) were transcribed from
the allele with G490T (Figure 2b). The lack of the normally
spliced mRNA in the XPV2KO sample indicates that the G to
T transversion at the last base of exon 4 had caused a loss of
the function of the 30 splice donor site of exon 4. Both the
abnormal mRNAs were produced by the activation of cryptic
splice sites and by an aberrant splicing between nucleotides
G and G at the AGGT or aggt sequence. The AGGT or aggt
sequence might have been recognized as an alternative
splice donor site because the original splice donor-site
sequence had been changed from AGgt to ATgt by G490T
mutation. The insertion in def A causes a frameshift, which
results in an alternate reading frame encoding 28 unrelated
amino acids before termination. The deletion in def B causes
an in-flame deletion of 30 amino acids (from G-134 to
K-163).
DISCUSSION
We employed IP analysis for the diagnosis of XPV. We
analyzed 16 patients who were diagnosed as having XPV,
Table 2. POLH mutations found in this study
Case no. Cell strain Nucleotide change Effect on protein Exon IP band
1 XPV1HM G490T (homo) Frameshift or large deletion1 4 
2 XPV2HM C1066T (homo) R 356 stop 9 
3 XPV3HM No mutation +
4 XPV6HM C725G (homo) S 242 stop 6 
5 XPV7HM G490T (homo) Frameshift or large deletion1 4 
6 XPV8HM C725G S 242 stop 6 
A1766C K589T 11
7 XPV10HM G490T (homo) Frameshift or large deletion1 4 
8 XPV11HM G916T (homo) E 306 stop 8 
9 XPV12HM del 1661A 554 Frameshift, stop at 584 11 
10 XPV1KO G490T Frameshift or large deletion1 4 
G916T E 306 stop 8
11 XPV2KO G490T (homo) Frameshift or large deletion1 4 
12 XPV3KO G349C (homo) A117P 4 Weak
13 XPV4KO C725G (homo) S 242 stop 6 
14 XPV5KO G490T (homo) Frameshift or large deletion1 4 
15 XPV6KO G916T (homo) E 306 stop 8 
16 XPV7KO No mutation +
IP, immunoprecipitation.
1164 Frameshift, stop at 192 or deletion from G-134 to K-163.
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both from clinical and cytological points of view, and, among
them, 14 patients did not have, or rarely had, normal POLH
protein. Moreover, all the 14 patients had gene alterations in
the POLH gene. There was good correlation between the
absence of an 83-kDa band in the IP analysis and the
presence of a POLH gene mutation. The diagnosis of XPV at
an early age is very difficult because patients often do not
show severe clinical symptoms, such as acute sunburn and
skin cancers of the sun-exposed areas, until a later age. In
addition, their UDSs and post-colony formations are usually
within normal levels. In the post-UV colony-forming assays,
the cells showed normal or slight sensitivity to UV, without
caffeine. Fourteen of the 15 strains showed a much higher
sensitivity to UV in the presence of caffeine; whereas, in
every experiment, the normal control did not exhibit such an
enhanced cell killing by UV in the presence of caffeine. The
clinical diagnosis of XPV has frequently been made when
individuals developed skin cancer at an earlier age. An IP
analysis, using anti-POLH antibodies, is a very useful method
for screening patients for XPV.
We detected seven germline mutations of the POLH gene
in Japanese patients with XPV, including three novel
mutations. Previously, four mutations were reported in three
Japanese XPV patients. They are G490T in XP43TO, G916T
in XP2SA, and A1603G and A1766C in ops4 (Masutani et al.,
1999; Itoh et al., 2000; Itoh and Linn, 2001) (Figure 3a).
Previously, we reported that a founder effect is observed in
XPA gene alterations in patients with XPA (Nishigori et al.,
1994). Also, in Japanese patients with XPV, we found three
predominant mutations, G490T, C725G, and G916T. Espe-
cially among 28 mutated alleles, 11 (39%) were G490T
mutations (Figure 3a). The other two mutations were detected
in five (18%) of the 28 alleles. These hot spots make genetic
diagnoses in Japanese patients with XPV more feasible. Of the
seven mutations, three were the same as found in three
previously reported Japanese patients (Masutani et al., 1999;
Itoh et al., 2000; Itoh and Linn, 2001). The C1066T mutation
in XPV2HM is the same as that found in European patients
with XPV. This is the only common mutation for those found
outside Japan (Gratchev et al., 2003) (Figure 3a).
The G490T mutation occurs in the splicing consensus
sequences at the exon–intron boundaries and thus creates
new cryptic splicing sites inside and outside the exon 4.
According to the method for the Shapiro splicing-probability
score, the scores for the two newly created 50 splice sites – the
mutated original splice site and the normal splice site – are
found to be 83.6 and 74.3, and 61.3 and 74.1, respectively
(Figure 2b) (Shapiro and Senapathy, 1987). So it is quite
possible that these abnormal splicings occur when patients
with XPV carry G490T.
A novel missense mutation A-117-P, found in XPV3KO, in
the highly conserved domain, is important for the hydro-
phobic core formation among species (Ling et al., 2001).
Moreover, the four types of missense mutations previously
reported were located in the N-terminal 407-amino acid. The
novel missense mutations in our study are also located in
codon 117, which is between the two previously reported
missense mutations, R111H and T122P, in the same
conserved residues (Broughton et al., 2002). We screened
50 unrelated Japanese individuals (100 alleles) by direct
sequencing for these types of mutations. No mutations were
found. Therefore, these mutations are unlikely to be rare
polymorphisms. Another missense mutation, K589T, is the
same as that previously reported in a Japanese XPV patient
(Itoh et al., 2000). Itoh et al. (2000) reported that this type of
mutation was absent in 52 unrelated Japanese individuals.
We also screened for additional 50 unrelated individuals for
this missense mutation and found that none of them had it.
These basic residues are highly conserved in humans and
mice (Yamada et al., 2000). On the basis of these facts, it is
most probable that these missense mutations are responsible
for the disease. In XPV8HM cells, that is, in compound
heterozygote cells with nonsense mutations and missense
mutations (S242stop and K589T), no 83 kDa band was
detected. Also, in XPV3KO cells with homozygous missense
mutations (G349C), a relatively weak band of POLH protein
was detected. These IP results indicate that these two
missense mutations can lead to the abnormal conformation
of the POLH protein that reduces the antigenic reactivity to
the anti-POLH antibodies. In addition, the conformation
change may facilitate the protein-degradation process. These
facts also support that these two missense mutations are
responsible for the pathogenesis of XPV.
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Figure 2. Aberrant splicing of POLH pre-mRNA in XPV1KO and XPV2KO
cells. (a) RT-PCR products from XPV1KO, XPV2KO, and a normal individual.
Sites of RT-PCR primers are shown schematically. M: marker 500 bp ladder.
(b) Schematic presentation of the abnormal splicing caused by G490T. Two
arrowheads and a small arrow indicate new abnormal splice sites and a
mutation site (G490T), respectively. Numbers in parentheses indicate Shapiro
splicing probability score.
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Among the 16 patients clinically diagnosed with XPV, 14
patients had gene alterations in the POLH gene and their
fibroblasts either did not express or barely expressed the
POLH protein. However, two patients did not harbor any
POLH mutations and their fibroblasts expressed the POLH
protein. The patient with XPV7KO developed actinic
keratosis and lentigo maligna at the age of 47 years. The
levels of UDS for the XPV3HM and the XPV7KO patients
were 70 and 101%, respectively (Table 1). Colony-forming
ability after UV was greatly reduced by the presence of
caffeine in both the XPV3HM and XPV7KO fibroblasts, which
strongly suggests that these patients have some deficiencies in
post-replication repair capability. Caffeine sensitization is
also seen in other complementation groups of XP (Cleaver,
1989) and the misclassification of XPC, XPE, and XPV has
been reported (Itoh et al., 2000). The cases that do not have
POLH mutations might be misclassified. However, these cells
have normal or almost normal levels of UV-induced UDS and
a D37 level in the post-UV colony-forming assay; it is difficult
to assign the complementation group to these cells either by
seeing the host cell reactivation after the transfection of the
cDNA of each XP complementation group, or by seeing the
recovery of the UV-induced UDS after cell hybridization with
other complementation groups. Another possibility is that
these patients have mutations in genes other than the POLH,
which are involved in some steps of a translesional synthesis,
such as Rad30B (McDonald et al., 1999), DinB1 (Ohashi
et al., 2000), or Rev1 (Lin et al., 1999).
To assess the genotype–clinical correlation, we summari-
zed the repair ability in terms of the UV survival assay, the
UDS, the mutated POLH protein, the age onset of skin
cancer, and the number of skin cancers (Table 1 and Figure
3b). The average age of onset of skin cancer was 45 years;
whereas, it is over 70 years in the general Japanese
population (Chaung et al., 1995). As for the mutated POLH
protein, mutations in this study result in various types of
truncated POLH protein (Figure 3b). Comparing the
XPV12HM, having a full conserved N-terminal region and
one half of the C-terminal region, with the XPV6HM and
XPV4KO mutations, having only the truncated N-terminal
region of the POLH protein, there was no obvious relation-
ship between the clinical manifestations, the UDS, and the
UV survival of these three patients. Because both kinds of
anti-POLH antibodies that we used in this study recognize the
C-terminal region, it is unknown whether a truncated POLH
protein, having the conserved N-terminal region, really exists
in XPV cells. Assessments of genotype–phenotype relation-
ships in patients with XPV are complicated because the
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clinical features are determined to a large extent by the
amount of exposure to sunlight, which, in turn, is related to
the age or the lifestyle of the patients. For now, we could not
find any evidence of genotype–phenotype correlation in XPV.
However, we did find a very useful and feasible way to find
patients with XPV at a very early stage, when their clinical
features are not fully complete, which prevents these patients
from presenting with skin cancers.
MATERIALS AND METHODS
Subjects
Sixteen cell strains, derived from patients clinically diagnosed with
XPV, were analyzed in this study (Table 1). The average age of the
patients was 57.1 years (34–82 years). Although all the patients
developed skin cancers and the average onset age of the skin cancers
was 45 years (22–69 years), non-XP Japanese had skin cancers even
after the age of 70 years. All the patients, except those with XPV3HM
and XPV7HM, gave their written consent for the investigations of
gene alterations, and those with XPV3HM and XPV7HM gave their
oral consent. We handled these two patients as anonymous, so that
no personal information other than their phenotypes would be
revealed. The Medical Ethics Committee of Kobe University and the
Medical Ethics Committee of Hamamatsu University approved this
work, which was conducted in accordance with the Declaration of
Helsinki Principles. The control group comprised 50 non-affected
unrelated Japanese individuals from the same area.
Cell culture
Primary cultured fibroblasts were grown from the skin biopsy
specimens obtained from patients clinically suspected of XPV.
Normal fibroblasts were obtained from volunteers who included a
50-year-old healthy woman, a 26-year-old healthy woman, and a
27-year-old healthy man. Cells from a patient with XPA (XP 6EH)
were also used as a positive control (Nishigori et al., 1994). All the
cell strains were maintained in Dulbecco’s modified minimum
essential medium, supplemented with 15% fetal calf serum in
5% carbon-dioxide air at 371C.
UVC irradiation
Germicidal lamps emitting predominantly 254 nm light (Toshiba
GL10, Toshiba Electric Co., Yokosuka, Japan) were used as a source
of UVC. Fluence rates were measured by the UV radiometers,
UV-254 (Topcon, Tokyo Kogaku Kikai KK, Tokyo, Japan).
Post-UV colony formation assay in the presence or absence
of caffeine
Cellular sensitivity to UVC was examined by the colony-forming
ability after UVC irradiation, as described previously (Nishigori
et al., 1994). Colony formation in the presence of caffeine was
carried out with exactly the same procedure, except that a medium
with 1 mM of caffeine was used after the UVC irradiation. In case the
plating efficiency was low, a medium containing 0.5 mM caffeine
was used.
Measurement of UDS after UV irradiation
The UV-induced UDS was measured as described previously
(Nishigori et al., 1994). Briefly, the cells were irradiated with
30 J/m2 of UVC and were then incubated in a medium containing
tritiated thymidine (0.37 MBq/ml, 25 Ci/mmol; Amersham, Little
Chalfont, UK) for 3 hours. Tritiated thymidine incorporated into the
nuclear DNA was detected by autoradiography. The number of
grains per nucleus was scored for 100 nuclei in each specimen.
IP analysis
IP analysis was performed as described (Thakur et al., 2001; Laposa
et al., 2003). Cells were solubilized in lysis buffer (100 mM
phosphate buffer pH 6.8, 0.5% Triton X-100) containing protease
inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 mg/ml of leupep-
tin, and aprotinin). An equal amount of protein (200 mg) was
incubated with rabbit polyclonal anti-POLH antibody sc-5592 (Santa
Cruz Biotechnology, Santa Cruz, CA) overnight and then with
protein A-agarose sc-2001 (Santa Cruz Biotechnology) overnight in a
cold room. The immunoprecipitates were subjected to an 8% SDS-
PAGE. Mouse mAb sc-17770 (Santa Cruz Biotechnology) against the
POLH protein was used as a primary antibody. Horseradish
peroxidase-linked anti-mouse IgG was used as a secondary probe.
The POLH protein was detected with the ECL-plus Western Blotting
Detection System (GE Health Care Corp., Piscataway, NJ).
Mutation analysis
Genomic DNAs were extracted from primary fibroblasts using a
standard phenol/chloroform method. Intronic primers (Table S1)
were designed according to the genomic DNA sequences that cover
the entire POLH gene (Genbank accession number AL355802 and
AL355602). Exons 1 through 11 of the POLH gene were amplified
from the genomic DNA and were directly sequenced with the PCR
primers on an ABI 310 sequencer according to the manufacturer’s
instructions. The mutations were confirmed using both forward and
reverse primers. For examining the SNP, the genomic DNAs (100
chromosomes) were purified from the peripheral blood of 50 non-
affected unrelated Japanese individuals, and were used as control
sequences.
RT-PCR and direct sequencing of the PCR products
Total RNA was extracted from the cultured fibroblasts. One
microgram of total RNA was reverse transcribed in the presence of
an oligo(dT)1218 primer. The cDNA was amplified with the primers
(RT-E1F: 50-GAGCCCTTCCATTTTCCTTC-30, RT-E10R: 50-CGTTTT
GCTGTGATTGAACG-30) encompassing exons 1 through 10 of the
POLH mRNA. The amplified products were purified and directly
sequenced with RT-PCR primers, as described above.
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